Advanced in Hypertrophic Cardiomyopathy (HCM)

Stephane Lafitte

Bordeaux, FR 
Advanced in Hypertrophic Cardiomyopathy (HCM)
Bordeaux, FR 
OverviewLocationsClinical Research

Overview

Stephane Lafitte practices in Bordeaux, France. Ms. Lafitte is rated as an Advanced expert by MediFind in the treatment of Hypertrophic Cardiomyopathy (HCM). Her top areas of expertise are Hypertrophic Cardiomyopathy (HCM), Cardiomyopathy, Tricuspid Regurgitation, Aortic Valve Stenosis, and Heart Transplant.

Her clinical research consists of co-authoring 81 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 18 articles in the study of Hypertrophic Cardiomyopathy (HCM).

Gender
Female

Locations

Bordeaux, France
Other Locations
Pessac-sur-dordogne, France
Paris, 75012, France
Rennes, France
40, Avenue Léon Blum, Beauvais, 60000, France
Amiens, 80054, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Safety and Performance Evaluation of the AccuCinch® Ventricular Restoration System for the Treatment of Heart Failure With or Without Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study
Safety and Performance Evaluation of the AccuCinch® Ventricular Restoration System for the Treatment of Heart Failure With or Without Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study
Enrollment Status: Active_not_recruiting
Publish Date: January 29, 2025
Intervention Type: Device
Study Phase: Not Applicable
Cardiac Remodeling and Prognosis in Secondar Tricuspid Regurgitation
Cardiac Remodeling and Prognosis in Secondar Tricuspid Regurgitation
Enrollment Status: Completed
Publish Date: April 12, 2023
Intervention Type: Other
Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI)
Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI)
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

81 Total Publications

Artificial intelligence-enhanced echocardiography in cardiovascular disease management.
Artificial intelligence-enhanced echocardiography in cardiovascular disease management.
Journal: Nature reviews. Cardiology
Published: July 08, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Lafitte's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile